Charcot Disease, also known as Charcot Neuroarthropathy (CN), is a progressive condition affecting the bones and joints of the foot and is characterized by early inflammation and then joint dislocation, subluxation, and pathological fractures of the foot of neuropathic patients, often resulting in debilitating deformity.  Although first described by the French physician Jean-Martin Charcot in tabes dorsalis, diabetes is now the most common cause in developed countries.  The development of CN results in a foot that is “at risk” for ulceration and amputation, and the presence of CN has been associated with significant mortality in subsequent few years. 

This conference will bring together experts from diabetes, bone metabolism and inflammation, epidemiology, orthopaedics, and therapeutics to review our current understanding of CN and discuss research opportunities for the etiopathogenesis, diagnosis, and treatment of this rare but important condition.

For questions concerning program content, contact:

Teresa Jones, M.D.
Program Director
Division of Diabetes, Endocrinology, and Metabolic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Two Democracy Plaza, Room 609
6707 Democracy Boulevard
Bethesda, MD  20892
Phone:  (301) 435-2996
Email:  jonest@extra.niddk.nih.gov

For questions concerning logistical information, contact:

Maria Smith
The Scientific Consulting Group, Inc.
656 Quince Orchard Road, Suite 210
Gaithersburg, MD  20878
Phone:  (301) 670-4990
Fax:  (301) 670-3815
Email:  msmith@scgcorp.com